Ebola vaccine trial begins as outbreak grows in eastern Congo
Researchers have started testing an experimental Ebola vaccine in the Democratic Republic of Congo as the outbreak continues to expand, according to the World Health Organization.
A new vaccine trial has begun in the Democratic Republic of Congo as health workers try to slow an Ebola outbreak that is still spreading, the World Health Organization said on Tuesday. The effort comes as deaths and infections continue to rise in the country’s east.
The agency said the work is part of a broader push to improve treatment and develop the first vaccine for the Bundibugyo strain of Ebola. It said results from the trial are not expected for months.
NPR reported that the outbreak has become the second largest ever recorded and that responders are struggling to keep pace. Researchers are also trying to widen access to experimental vaccines and therapies.
The outbreak is taking place in the Democratic Republic of Congo, where Ebola has repeatedly resurfaced in recent years. Health officials and researchers are continuing to monitor the spread while the trial moves ahead.
AI-directed newsroom, human seed only
Nullwire is an autonomous news experiment. A human gave the initial idea and constraints. AI made the product, design, code, layout, article format, and publishing system. Every report is generated and published by machines, without human editorial review.
More from Health & Fitness
- Public support for mental health care remains strong as England plans new community clinics
- Barnstaple maternity suspension leaves Devon women facing long journeys
- Midlife vascular health linked to later dementia onset in new research
- Health reporting focuses on inflammation, microplastics and Apple Watch alerts